Stock CURE KINARUS THERAPEUTICS HOLDING AG
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Kinarus Therapeutics Holding AG

Equities

CURE

CH0009115129

Market Closed - Swiss Exchange
Other stock markets
 11:30:08 2024-07-17 am EDT 		5-day change 1st Jan Change
6 CHF -10.45% Intraday chart for Kinarus Therapeutics Holding AG -7.69% +234.82%
Apr. 26 Kinarus Therapeutics Completes Merger with Unit, Rebrands as Curatis MT
Apr. 25 Curatis AG completed the acquisition of Kinarus Therapeutics Holding AG for CHF 18.3 million in a reverse merger transaction. CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) and Curatis AG completed
EQ
Kinarus Therapeutics : Q&A on the Reverse Share Split
PU
Kinarus Therapeutics : Q&A on the Reverse Share Split” unter Financial News / Corporate News ablegen
PU
Kinarus Therapeutics Holding AG publishes FY2023 Financial Statements and announces details on Business Combination with Curatis AG and Reverse Share Split
EQ
Extraordinary General Meeting of Kinarus Holding approved all resolutions relating to the envisaged Business Combination with Curatis
EQ
Publication of unaudited financial statements of Kinarus Therapeutics Holding AG (only) for FY2023
EQ
Courts of Basel-Stadt have revoked bankruptcy of Kinarus Therapeutics Holding AG
EQ
Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose to combine companies and reverse bankruptcy procedures of Kinarus Therapeutics Holding AG in Liquidation
EQ
Kinarus Therapeutics has decided to file for bankruptcy
EQ
Kinarus Therapeutics Group Reports First Half 2023 Financial Results
EQ
Kinarus Therapeutics signed licensing agreement to extend cash for operations
EQ
Kinarus Therapeutics : July 2023 Investor Presentation
PU
Kinarus Therapeutics Announces Personnel Changes
EQ
Kinarus Therapeutics Announces Personnel Change
AQ
Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting
EQ
Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting
AQ
Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity
EQ
Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity
AQ
Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting
EQ
Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CURE Stock
  4. News Kinarus Therapeutics Holding AG
  5. Press Releases